NeuroMab™ Mouse Anti-Beta Amyloid (CBP1930)

Product Overview

Description

Mouse anti-human beta amyloid antibody, clone DE2B4 recognizes human beta amyloid peptide, which is the main protein component of the amyloid core in neural plaques.
In immunohistology, the antibody can detect extracellular amyloid β with senile plaques and vascular amyloid in the brain of Alzheimer's disease.

Immunogen

A synthetic peptide composed of residues 1-17 of amyloid beta protein.

Species Reactivity

Human

Clonality

Monoclonal

Host Species

Mouse

Isotype

IgG1

Clone Number

CBP1930

Applications

ELISA; IF; IHC-P; IP

Relevant Diseases

Alzheimer's Disease

Research Areas

Neuroregeneration

Product Properties

Form

Liquid

Formulation

PBS; 0.09% Sodium Azide

Preservatives

Yes

Concentration

1.0 mg/ml

Purification

Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant.

Endotoxin Level

Low Endotoxin

Shipping

The product is shipped at 4°C. Upon receipt, store it immediately at the temperature recommended below.

Storage

Store at +4°C or at -20°C if preferred.

This product should be stored undiluted.

Storage in frost-free freezers is not recommended. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.

Research Use Only

For research use only, not for diagnostic or therapeutic use.

Target

APP

Official Name

APP

Full Name

Amyloid Precursor Protein

Alternative Names

APP; AAA; ABETA; ABPP; AD1; APPI; CTFgamma; CVAP; PN-II; PN2; amyloid beta precursor protein; preA4

Gene ID

351 (Human); 11820 (Mouse); 54226 (Rat)

Uniprot ID

P05067 (Human); P12023 (Mouse); P08592 (Rat)

References

1. Lee, M.H. et al. (2010) TGF-β induces TIAF1 self-aggregation via type II receptor-independent signaling that leads to generation of amyloid β plaques in Alzheimer's disease.
2. Chang, J.Y. et al. (2012) TIAF1 self-aggregation in peritumor capsule formation, spontaneous activation of SMAD-responsive promoter in p53-deficient environment, and cell death.
3. Koronyo-Hamaoui, M. et al. (2011) Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model.

Publications